当前位置:首页 - 行情中心 - 丰原药业(000153) - 财务分析 - 现金流量表

丰原药业

(000153)

  

流通市值:27.61亿  总市值:27.83亿
流通股本:4.61亿   总股本:4.65亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,708,829,372.27874,594,192.563,822,104,543.712,477,831,768.62
  收到的税费返还8,445,011.797,682,597.3519,314,096.913,542,584.15
  收到其他与经营活动有关的现金51,827,656.1229,673,107.22211,266,293.0266,044,948.6
  经营活动现金流入小计1,769,102,040.18911,949,897.134,052,684,933.642,547,419,301.37
  购买商品、接受劳务支付的现金1,208,844,211.72673,812,355.422,713,306,793.061,713,106,954.99
  支付给职工以及为职工支付的现金203,363,291.85112,091,578.35396,934,323.05309,789,737.35
  支付的各项税费101,236,577.4342,285,955.87196,031,860.5149,514,812.42
  支付其他与经营活动有关的现金171,985,641.6274,459,110.42627,114,194.41286,194,244.81
  经营活动现金流出小计1,685,429,722.62902,649,000.063,933,387,171.022,458,605,749.57
  经营活动产生的现金流量净额83,672,317.569,300,897.07119,297,762.6288,813,551.8
二、投资活动产生的现金流量:
  收回投资收到的现金--1,400,0001,400,000
  取得投资收益收到的现金--8,557,138.88,477,122.5
  处置固定资产、无形资产和其他长期资产收回的现金净额24,520.5670406,922.71131,262.75
  投资活动现金流入小计24,520.567010,364,061.5110,008,385.25
  购建固定资产、无形资产和其他长期资产支付的现金39,054,628.8930,116,799.8220,605,804.57165,372,565.71
  投资支付的现金--60,000,000-
  投资活动现金流出小计39,054,628.8930,116,799.8280,605,804.57165,372,565.71
  投资活动产生的现金流量净额-39,030,108.39-30,116,129.8-270,241,743.06-155,364,180.46
三、筹资活动产生的现金流量:
  取得借款收到的现金831,917,291.65390,746,994.031,534,129,075.21967,314,958.53
  收到其他与筹资活动有关的现金130,000,000130,000,000--
  筹资活动现金流入小计961,917,291.65520,746,994.031,534,129,075.21967,314,958.53
  偿还债务支付的现金591,369,545.51274,325,545.511,234,242,029.58791,242,029.58
  分配股利、利润或偿付利息支付的现金60,688,755.227,080,955.581,164,155.7770,053,675.5
  支付其他与筹资活动有关的现金12,482,148.795,075,610.68155,604,116.3320,227,814.6
  筹资活动现金流出小计664,540,449.52286,482,111.691,471,010,301.68881,523,519.68
  筹资活动产生的现金流量净额297,376,842.13234,264,882.3463,118,773.5385,791,438.85
四、汇率变动对现金及现金等价物的影响-60,608.39-15,647.61-17,174.26-8,113.59
五、现金及现金等价物净增加额341,958,442.91213,434,002-87,842,381.1719,232,696.6
  加:期初现金及现金等价物余额128,469,642.69128,469,642.69216,312,023.86216,312,023.86
  期末现金及现金等价物余额470,428,085.6341,903,644.69128,469,642.69235,544,720.46
补充资料:
  净利润70,277,823.39-94,804,169.89-
  资产减值准备16,975,181.39-33,415,538.92-
  固定资产和投资性房地产折旧50,485,411.11-104,433,142.53-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧50,485,411.11-104,433,142.53-
  无形资产摊销9,034,059.25-16,895,821.21-
  长期待摊费用摊销8,614,110.51-14,592,506.24-
  处置固定资产、无形资产和其他长期资产的损失808.33-326,419.46-
  固定资产报废损失303,459.63-172,125.98-
  公允价值变动损失5,965,593.5-2,650,611.03-
  财务费用15,173,884.68-34,898,880.81-
  投资损失-10,453,128.78--8,556,538.8-
  递延所得税-7,313,811.97--6,454,122.22-
  其中:递延所得税资产减少15,224,994.92--5,839,575.75-
    递延所得税负债增加-22,538,806.89--614,546.47-
  存货的减少18,679,559.98-46,048,966.86-
  经营性应收项目的减少-41,102,789.01--52,619,409.65-
  经营性应付项目的增加-69,508,109.66--188,351,063.69-
  其他4,368,621.59---
  现金的期末余额470,428,085.6-128,469,642.69-
  减:现金的期初余额128,469,642.69-216,312,023.86-
  现金及现金等价物的净增加额341,958,442.91--87,842,381.17-
公告日期2026-08-282026-04-292026-04-292025-10-24
审计意见(境内)标准无保留意见
TOP↑